ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients

Cancer Commun (Lond). 2022 Jul;42(7):663-667. doi: 10.1002/cac2.12296. Epub 2022 Apr 29.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / metabolism
  • Cell Line, Tumor
  • Disease-Free Survival
  • Female
  • Humans
  • Interferons / metabolism
  • Receptors, Estrogen / metabolism
  • Triple Negative Breast Neoplasms*

Substances

  • Receptors, Estrogen
  • Interferons